Accelerate Vaccine Development | Antibody Profiling

Unlock the Potential of Sengenics Technology in Vaccine Development

Identify protective antibodies, quantify candidate binding, and evaluate neutralization efficacy with Sengenics protein microarrays powered by innovative KREX^® technology. We deliver comprehensive vaccine research solutions, offering custom protein panels and ready-to-use microarrays with up to 1800+ antigens.

Explore Our Microarrays

Don’t see what you need? Learn about our Custom Protein Assays.

Interested in running the assays in your own lab? Contact us

Featured Application

Infectious Disease →

Related Resources

Publication: Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort →

Ready to accelerate your program?

Let’s discuss your needs

Sengenics, a functional proteomics company, is committed to advancing precision medicine by empowering researchers with biologically relevant and actionable immunoproteomic insights across a broad spectrum of diseases. At the heart of its mission, Sengenics offers advanced, high-throughput tools using proprietary technology to precisely detect autoantibody biomarkers and protein interactions for basic, translational, and clinical research. Its robust tools have been leveraged by top pharmaceutical companies and leading research institutions to enhance disease understanding and streamline the biomarker pipeline.

Design and development by RainCastle Communications.

Accelerate Vaccine Development with Antibody Profiling

Unlock the Potential of Sengenics Technology in Vaccine Development

Don’t see what you need? Learn about our Custom Protein Assays.

Interested in running the assays in your own lab? Contact us

Featured Application

Related Resources

Ready to accelerate your program?

Fill in the form to download the publication

Watch the video

Watch the video

Autoantibody-Based Diagnostic Biomarkers: Technological Approaches to Discovery and Validation

Read the Review

Watch the video